Regulation of RNA metabolism and cell growth control by SR protein kinases
SR 蛋白激酶对 RNA 代谢和细胞生长控制的调节
基本信息
- 批准号:8797321
- 负责人:
- 金额:$ 32.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingAnimal ModelBiochemicalBiological ProcessCancer BiologyCatalysisCell NucleusCell modelCellsComplementCytoplasmDevelopmentDissectionEGF geneEnzymatic BiochemistryEpigenetic ProcessEventFeedbackFundingGenome StabilityHigh-Throughput Nucleotide SequencingHumanKnock-outKnockout MiceMalignant NeoplasmsMammalian CellMediatingMetabolismMolecularMolecular ChaperonesMusPathway interactionsPharmaceutical PreparationsPhasePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPost-Translational Protein ProcessingProcessPropertyProtein KinaseProteinsRNARNA SplicingRS proteinRegulationReporterResistanceRoleSeriesSignal TransductionSignal Transduction PathwayStructureSubstrate SpecificityTechnologyTestingTransducersacrosome stabilizing factorbasecell growthcell transformationhigh throughput technologyinsightnew technologynovelresearch studyresponsetumorigenesis
项目摘要
DESCRIPTION (provided by applicant):
This project focuses on SRPK1 and SRPK2, major kinases responsible for the phosphorylation of SR proteins and RS domain-containing splicing factors and regulators in mammalian cells. We demonstrated that both of these splicing kinases are anchored in the cytoplasm through interactions with molecular chaperons and that they can be induced to translocate to the nucleus in response to cellular signaling. We recently discovered that these kinases are direct substrates of activated Akt, representing a new branch of the EGF pathway to regulate SR protein phosphorylation and alternative splicing in the nucleus. Interestingly, these splicing kinases also modulate the functional state of Akt via a novel feedback mechanism, and as a functional consequence, we found that depletion of SRPK1 is sufficient to transform immobilized MEFs. Based on these recent findings, we now propose three specific aims to (1) define SRPKs as signal transducers for regulated splicing using global approaches in combination with biochemical dissection of key signal transduction pathways involved, (2) elucidate the mechanism underlying SRPK-mediated signaling by characterizing specific molecular switches induced by upstream signaling events, and (3) determine the function and regulatory role of SRPKs in tumorigenesis by pursuing the hypotheses that SRPKs may regulate Akt and synergize with other key regulators in the Akt pathway to determine cell fate and promote tumorigenesis. The proposed studies are expected to have broad implications on regulated splicing, signal transduction and cancer biology.
描述(由申请人提供):
该项目的重点是SRPK1和SRPK2,主要激酶负责SR蛋白磷酸化和RS域包含剪接因子和调节剂在哺乳动物细胞。我们证明了这两种剪接激酶都通过与分子伴侣的相互作用锚定在细胞质中,并且它们可以被诱导易位到细胞核中以响应细胞信号。我们最近发现,这些激酶是激活Akt的直接底物,代表EGF途径的一个新的分支,以调节SR蛋白磷酸化和选择性剪接在细胞核中。有趣的是,这些剪接激酶还通过一种新型反馈机制调节Akt的功能状态,作为功能结果,我们发现SRPK 1的耗尽足以转化固定的MEF。基于这些最新发现,我们现在提出三个具体目标:(1)使用全局方法结合对所涉及的关键信号转导途径的生化解剖来定义SRPK作为调节剪接的信号转导子,(2)通过表征由上游信号事件诱导的特定分子开关来阐明SRPK介导的信号转导的潜在机制,以及(3)通过以下假设确定SRPKs在肿瘤发生中的功能和调节作用:SRPKs可以调节Akt并与Akt途径中的其他关键调节剂协同作用以决定细胞命运并促进肿瘤发生。这些研究将对调控剪接、信号转导和肿瘤生物学产生广泛的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIANG-DONG FU其他文献
XIANG-DONG FU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIANG-DONG FU', 18)}}的其他基金
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8734415 - 财政年份:2013
- 资助金额:
$ 32.87万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9081584 - 财政年份:2013
- 资助金额:
$ 32.87万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8915157 - 财政年份:2013
- 资助金额:
$ 32.87万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8647698 - 财政年份:2013
- 资助金额:
$ 32.87万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9310249 - 财政年份:2013
- 资助金额:
$ 32.87万 - 项目类别:
FUNCTION AND REGULATION OF THE HUMAN SPLICING FACTOR SC35
人类剪接因子 SC35 的功能和调控
- 批准号:
7845881 - 财政年份:2009
- 资助金额:
$ 32.87万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 32.87万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 32.87万 - 项目类别:
Research Grants














{{item.name}}会员




